Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel network

Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis

(2021) Xinhua Chen et al.   Lancet Global Health

Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection

(2021) Charlotte Manisty et al.   EBioMedicine

Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers

(2021) Ross J. Harris et al.   JOURNAL OF INFECTION

The impact of primary care supported shielding on the risk of mortality in people vulnerable to COVID-19: English sentinel network matched cohort study

(2021) Azmaeen Zarif et al.   JOURNAL OF INFECTION

Seroprevalence of anti-SARS-CoV-2 IgG at the first epidemic peak in French Guiana, July 2020

(2021) Claude Flamand et al.   PLoS Neglected Tropical Diseases

Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study

(2020) Simon de Lusignan et al.   LANCET INFECTIOUS DISEASES

Don't blame the BAME : Ethnic and structural inequalities in susceptibilities to COVID ‐19

(2020) Gillian R Bentley   AMERICAN JOURNAL OF HUMAN BIOLOGY

SARS-CoV-2 seroprevalence in COVID-19 hotspots

(2020) Isabella Eckerle et al.   LANCET

Excess mortality from COVID-19 in an English sentinel network population

(2020) Mark Joy et al.   LANCET INFECTIOUS DISEASES

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

(2020) Quan-Xin Long et al.   NATURE MEDICINE

Excess mortality in the first COVID pandemic peak: cross-sectional analyses of the impact of age, sex, ethnicity, household size, and long-term conditions in people of known SARS-Cov-2 status in England

(2020) Mark Joy et al.   BRITISH JOURNAL OF GENERAL PRACTICE

RISK FACTOR ANALYSIS FOR SARS-COV-2 SEROPOSITIVITY WITHIN ASSISTED REPRODUCTIVE

(2020) Nicolás Prados et al.   FERTILITY AND STERILITY

Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased?

(2020) Saki Takahashi et al.   JOURNAL OF INFECTIOUS DISEASES

A dual antigen ELISA allows the assessment of SARS-CoV-2 antibody seroprevalence in a low transmission setting

(2020) Sarah M Hicks et al.   JOURNAL OF INFECTIOUS DISEASES

Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study

(2020) Shuchi Anand et al.   LANCET

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison

(2020) Mark Ainsworth et al.   LANCET INFECTIOUS DISEASES

Are we underestimating seroprevalence of SARS-CoV-2?

(2020) Stephen Burgess et al.   BMJ-British Medical Journal

High seroprevalence but short‐lived immune response to SARS‐CoV‐2 infection in Paris

(2020) François Anna et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Programming With Models: Writing Statistical Algorithms for General Model Structures With NIMBLE

(2017) Perry de Valpine et al.   JOURNAL OF COMPUTATIONAL AND GRAPHICAL STATISTICS